The Lancet2d
The potential for annual long-acting HIV pre-exposure prophylaxis
Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...
‘Annual shot to prevent HIV proven safe’
The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...
The American Journal of Managed Care1d
Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
Applied Clinical Trials Online12h
Phase I Trial Supports Development of Once-Yearly Lenacapavir as Long-Acting HIV PrEP Option
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
News-Medical.Net on MSN1d
Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIV
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
HIV prevention medication ‘could one day be a yearly jab’ – study suggests
An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...
GlobalData on MSN1d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
India Today on MSN1d
Bitten by a dog? Rabies vaccine is not enough, you need more to stay safe
Even a minor scratch from a potentially rabid animal requires immediate medical attention. According to Dr. Neha Rastogi ...
Gilead posts early Phase 1 data for once-yearly HIV PrEP therapy
Gilead (GILD) stock in focus as its HIV anti-viral lenacapavir shows promise in HIV prevention with once-yearly PrEP ...
Dog Bite? Rabies Vaccine Shots Alone Won’t Save You—Here’s What You Must Do Next
Rabies is a deadly disease that spreads through animal bites, mostly from dogs. Experts warn that just getting a vaccine may not be enough—some cases need rabies immunoglobulin (RIG) for protection., ...
BioSpace1d
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...
Medscape16h
Antiretrovirals Alone Don’t Delay Language Development in Exposed Children
Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...